Cargando…
Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
BACKGROUND: Patients with rheumatoid arthritis (RA) have an increased risk of coronary artery disease (CAD) above the baseline. Baicalin possesses beneficial effects against both RA and CAD, but little is know on its clincial efficacy among patients manifesting both CAD and RA. METHODS: Three hundre...
Autores principales: | Hang, Yuanxing, Qin, Xian, Ren, Tianli, Cao, Jianing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015450/ https://www.ncbi.nlm.nih.gov/pubmed/29935544 http://dx.doi.org/10.1186/s12944-018-0797-2 |
Ejemplares similares
-
Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled study
por: Kolahi, Sousan, et al.
Publicado: (2015) -
A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis
por: de los Angeles Pineda, Maria, et al.
Publicado: (2011) -
A double-blind placebo-controlled randomized trial of oral saffron in the treatment of rheumatoid arthritis
por: Sahebari, Maryam, et al.
Publicado: (2021) -
Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study
por: Buondonno, Ilaria, et al.
Publicado: (2017) -
Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial
por: Cohen, Stanley, et al.
Publicado: (2020)